| PERIOD ENDING | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | 30-Sep-08 | | Total Revenue | 776,592 | 745,862 | 753,045 | 734,726 | | Cost of Revenue | 433,340 | 419,708 | 419,748 | 405,936 | | | Gross Profit | 343,252 | 326,154 | 333,297 | 328,790 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 170,003 | 166,872 | 169,378 | 166,685 | | Non Recurring |
-
|
-
|
-
|
-
| | Others | 21,579 | 21,152 | 21,253 | 19,474 | | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 151,670 | 138,130 | 142,666 | 142,631 | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 17,496 | (2,641) | (6,580) | (9,433) | | Earnings Before Interest And Taxes | 169,166 | 135,489 | 136,086 | 133,198 | | Interest Expense |
-
|
-
|
-
|
-
| | Income Before Tax | 169,166 | 135,489 | 136,086 | 133,198 | | Income Tax Expense | 27,911 | 22,357 | 23,798 | 20,370 | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | 141,255 | 113,132 | 112,288 | 112,828 | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 141,255 | 113,132 | 112,288 | 112,828 | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | $141,255 | $113,132 | $112,288 | $112,828 |
|
0.20% Nasdaq 
0.14%
Income Statement
